Blog - SourcePeptides.co Skip to content
Free Shipping On Every Order

Blog

Oxytocin Peptide Research Guide: Mechanisms, Neuropeptide Biology & Preclinical Study Findings (2026)

Oxytocin is a nine-amino-acid neuropeptide that has emerged as one of the most extensively studied signaling molecules in preclinical neuroscience. First characterized structurally in the early 1950s, oxytocin research has since expanded far beyond its originally observed physiological roles, with laboratory investigations now exploring its interactions with social behavior circuits, stress-response pathways, autonomic regulation, and […]

Read more →

GHK-Cu 50MG Research Guide: Copper Peptide Concentration Biology, Dosing Variables & Preclinical Study Findings (2026)

GHK-Cu (glycyl-L-histidyl-L-lysine copper complex) has emerged as one of the most extensively investigated copper-binding peptides in preclinical research, with particular interest surrounding higher-concentration formats such as the 50MG research quantity. As a naturally occurring tripeptide that forms a stable complex with copper(II) ions, GHK-Cu has been examined across a diverse range of biological systems — […]

Read more →

MT-2 Nasal Spray Research Guide: Melanocortin Biology & Preclinical Findings (2026)

MT-2 (Melanotan II) is a synthetic cyclic heptapeptide analogue of alpha-melanocyte-stimulating hormone (α-MSH) that has been extensively studied in preclinical models for its interactions with the melanocortin receptor system. Research into MT-2 nasal spray delivery formats has grown substantially as investigators explore how transmucosal administration may influence the pharmacokinetic profile of this compound compared to […]

Read more →

BPC-157 Side Effects Research Guide: What Preclinical Studies Reveal About Safety, Liver Impact & Adverse Event Data (2026)

BPC-157 adverse event research has become one of the most actively queried areas in peptide biology, as investigators seek to understand how this synthetic pentadecapeptide behaves across a range of preclinical model systems. Derived from a sequence found in gastric juice proteins, BPC-157 has been the subject of numerous laboratory investigations examining not only its […]

Read more →

TB-500 Oral Bioavailability Research Guide: Mechanisms, Absorption Biology & Preclinical Study Findings (2026)

TB-500, the synthetic analogue of Thymosin Beta-4, has attracted sustained attention in peptide research due to its involvement in actin-binding dynamics and tissue-level biology. As preclinical investigations expand, researchers have increasingly turned their focus to a fundamental question in peptide pharmacology: TB-500 oral bioavailability. Understanding how this peptide behaves when introduced via gastrointestinal routes — […]

Read more →

15 Research Peptides Under $100: Best Value Compounds for Labs (2026)

Budget planning is a genuine consideration for any research program, and identifying high-value research peptides under $100 can meaningfully expand what a laboratory is able to investigate without compromising on compound quality or scientific breadth. The peptide research landscape in 2026 includes a remarkably diverse range of mechanisms — from growth hormone secretagogue biology and […]

Read more →

PT-141 Nasal Spray vs Injectable: Delivery Method Research Compared (2026)

PT-141, also known as bremelanotide, is a synthetic melanocortin peptide that has attracted significant interest in preclinical research settings due to its interaction with melanocortin receptor subtypes — particularly MC3R and MC4R. As laboratory investigation of this compound has expanded, researchers have increasingly focused not just on the peptide’s receptor biology, but on how delivery […]

Read more →

GLP-3 (R) Peptide Research Guide: Triple Receptor Agonist Biology & Preclinical Study Findings (2026)

GLP-3 (R) represents one of the most structurally sophisticated compounds under active investigation in metabolic peptide research. As a triple receptor agonist designed to engage GLP-1 receptors, GIP receptors, and glucagon receptors simultaneously, GLP-3 (R) occupies a unique position in the landscape of incretin-related research peptides. Studies have investigated how this simultaneous multi-receptor engagement produces […]

Read more →

VIP Peptide Research Guide: Vasoactive Intestinal Peptide Mechanisms, Receptor Biology & Preclinical Study Findings (2026)

Vasoactive intestinal peptide (VIP) is a 28-amino acid neuropeptide that has attracted significant scientific interest across multiple research disciplines. First isolated from porcine intestinal tissue in 1970, VIP peptide research has since expanded to explore its roles in neuroimmune signaling, smooth muscle biology, and circadian rhythm regulation. Its broad receptor expression and multi-system activity make […]

Read more →

FDA Peptide Regulations 2026: Category 1 Classifications, the Compounding Ban & Research Availability

The regulatory landscape surrounding peptides underwent significant changes in 2025 and into 2026, reshaping how researchers, laboratories, and procurement teams approach peptide acquisition and study design. Understanding the FDA’s current classification framework — particularly the distinction between Category 1 peptides subject to compounding restrictions and those that remain accessible for legitimate laboratory research — is […]

Read more →